Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS / AMPK / mTOR pathway
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7785 ↗At a glance
Journal article in Phytotherapy Research, 2023. Written by Luping Wang and 9 co-authors. Institution: College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, People's Republic of China. Major MEDLINE topics: Saponins, Triterpenes, Prostatic Neoplasms. Cited 12 times so far (Crossref); 32 references. Funded by: Basic Public Welfare Research Program of Zhejiang Province, the Key R&D Program of Zhejiang.
Abstract (original language)
Capilliposide B (CPS‐B), a novel oleanane triterpenoid saponin derived from Lysimachia capillipes Hemsl, is a potent anticancer agent. However, its anticancer mechanism remains elusive. In the present study, we demonstrated the potent anti‐tumor activity and molecular mechanism of CPS‐B both in vitro and in vivo. Proteomic analysis using isobaric tags for relative and absolute quantitation techniques suggested that CPS‐B modulated autophagy in prostate cancer (PC). Moreover, Western blotting showed that both autophagy and epithelial–mesenchymal transition occurred place after CPS‐B treatment in vivo, which was also proven in PC‐3 cancer cells. We deduced that CPS‐B inhibited migration by inducing autophagy. We examined the accumulation of reactive oxygen species (ROS) in cells, and in downstream pathways, LKB1 and AMPK were activated while mTOR was inhibited. Transwell experiment results showed that CPS‐B inhibited the metastasis of PC‐3 cells and that this effect was significantly attenuated after pretreatment with chloroquine, indicating that CPS‐B inhibited metastasis via autophagy induction. Altogether, these data suggest that CPS‐B is a potential therapeutic agent for cancer treatment that acts by inhibiting migration through the ROS/AMPK/mTOR signaling pathway.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, People's Republic of China.
- Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
- Marine Science College, Zhejiang Ocean University, Zhoushan, Zhejiang, People's Republic of China.
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, People's Republic of China.
ORCID profiles: Luping Wang
Funding
- Basic Public Welfare Research Program of Zhejiang Province
- the Key R&D Program of Zhejiang
Cite
APA
Wang, L., Han, H., Feng, Y., Ma, J., Han, Z., Li, R., Zhu, W., Li, S., Tian, J., & Zhang, L. (2023). Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS / AMPK / mTOR pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.7785
Vancouver
Wang L, Han H, Feng Y, Ma J, Han Z, Li R, et al. Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS / AMPK / mTOR pathway. Phytotherapy Research. 2023. doi:10.1002/ptr.7785
BibTeX
@article{Wang2023,
author = {Wang, Luping and Han, Haote and Feng, Yue and Ma, Jiahui and Han, Zhuo and Li, Ruyi and Zhu, Wei and Li, Shouxin and Tian, Jingkui and Zhang, Lin},
title = {Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS / AMPK / mTOR pathway},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7785}
}
EUVIMED